Effect of compliance and dosage adaptation of long term aspirin on platelet function with PFA-100 in patients after myocardial infarction
about
Aspirin resistance: current status and role of tailored therapyNon-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patientsExpanding the recognition and assessment of bleeding events associated with antiplatelet therapy in primary care.Aspirin resistance: disparities and clinical implications.Overcoming aspirin treatment failure in diabetes.Aspirin resistance: a clinical review focused on the most common cause, noncompliance.
P2860
Effect of compliance and dosage adaptation of long term aspirin on platelet function with PFA-100 in patients after myocardial infarction
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Effect of compliance and dosag ...... ts after myocardial infarction
@ast
Effect of compliance and dosag ...... ts after myocardial infarction
@en
Effect of compliance and dosag ...... ts after myocardial infarction
@nl
type
label
Effect of compliance and dosag ...... ts after myocardial infarction
@ast
Effect of compliance and dosag ...... ts after myocardial infarction
@en
Effect of compliance and dosag ...... ts after myocardial infarction
@nl
prefLabel
Effect of compliance and dosag ...... ts after myocardial infarction
@ast
Effect of compliance and dosag ...... ts after myocardial infarction
@en
Effect of compliance and dosag ...... ts after myocardial infarction
@nl
P2093
P356
P1476
Effect of compliance and dosag ...... ts after myocardial infarction
@en
P2093
Gerhard Strupp
Jürgen Bohner
Klaus-Werner von Pape
Tassilo Bonzel
P304
P356
10.1160/TH05-04-0889
P407
P577
2005-10-01T00:00:00Z